DocWire News Editors

DocwireNews

Although congenital heart disease (CHD) mortality has reduced among all U.S. age groups, racial differences persist, according to a study presented at the ACC.20 World Congress of Cardiology. 
“Recently, there is a significant decrease in mortality from congenital heart disease (CHD) in newborns and infants, but long–term mortality in older children and adults remains to be studied,” the researchers wrote in their abstract. 
To conduct this study, they used the Center for Disease Control Multiple Cause of Death registry to assess mortality trends from 2007-2017. They used ICD-10 codes to identify CHD as both a related and underlying cause of mortality and calculated the overall of percentage of change in mortality by subtracting the rate in 2007 from the rate in 2017, then dividing by the rate in 2007. 
From 2007 to 2017, there were 27,271 CHD-related deaths and 16,222 deaths resulting from CHD (age-standardized mortality rates, 7.88 and 4.73 per 1,000,000 respectively) with 76.65% of deaths occurring during adulthood. During this period, researchers observed that mortality resulting from CHD declined 21% overall. Moreover, mortality resulting from CHD significantly declined among all race-ethnicities studied. However, the researchers noted, disparities persisted, overall and across all age groups.  The Of note, mortality resulting from CHD was consistently higher among non-Hispanic blacks compared with non-Hispanic whites. 
Umapathi K. Long Term Mortality Trends Among Children and Adults with Congenital Heart Disease in The United States From 2007-2017. Presented at the ACC.20 World Congress of Cardiology; March 28-30, Chicago, IL.

Although congenital heart disease (CHD) mortality has reduced among all U.S. age groups, racial differences persist, according to a study presented at the ACC.20 World Congress of Cardiology. “Recently, there is a significant decrease in mortality from congenital heart disease (CHD) in newborns and infants, but long–term mortality in older children and adults remains to be studied,” the researchers wrote in their abstract. To conduct this study, they used the Center for Disease Control Multiple Cause of Death registry to assess mortality trends from 2007-2017. They used ICD-10 codes to identify CHD as both a related and underlying cause of mortality and calculated the overall of percentage of change in mortality by subtracting the rate in 2007 from the rate in 2017, then dividing by the rate in 2007. From 2007 to 2017, there were 27,271 CHD-related deaths and 16,222 deaths resulting from CHD (age-standardized mortality rates, 7.88 and 4.73 per 1,000,000 respectively) with 76.65% of deaths occurring during adulthood. During this period, researchers observed that mortality resulting from CHD declined 21% overall. Moreover, mortality resulting from CHD significantly declined among all race-ethnicities studied. However, the researchers noted, disparities persisted, overall and across all age groups.  The Of note, mortality resulting from CHD was consistently higher among non-Hispanic blacks compared with non-Hispanic whites. Umapathi K. Long Term Mortality Trends Among Children and Adults with Congenital Heart Disease in The United States From 2007-2017. Presented at the ACC.20 World Congress of Cardiology; March 28-30, Chicago, IL.

Rebecca Shatsky, MD

ASCO 2025 Highlights: Dr. Rebecca Shatsky on Evolving Therapies in HR+ Breast Cancer

HR Breast Cancer

Izzah Nawaz

New Genetic Study Identifies Two Key Genes Linked to Ulcerative Colitis Risk

Gastroenterology

David M. Waterhouse, MD, MPH

Clinical Trial Gaps in TNBC: New Data Underscores Access Inequities for Black Women

Triple-Negative Breast Cancer

Latest News

Long Term Mortality Trends Among Children and Adults with Congenital Heart Disease in The United States From 2007-2017

ACC 2020 Conference

Although congenital heart disease (CHD) mortality has reduced among all U.S. age groups, racial differences persist, according to a study presented at the ACC.20 World ...

Long Term Mortality Trends Among Children and Adults with Congenital Heart Disease in The United

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Diabetes

Obesity

Metabolic Care Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe